
Shares of industrial products maker Fortive FTV.N down 1% at $48 in premarket trading
Barclays downgrades rating to "equal-weight" from "overweight", also cuts PT to $54 from $58
The new PT still represents a 10.8% upside to the stock's last close
Barclays says co's second-half outlook seems tough to achieve, with slow growth and limited capital deployment
Notes that without renewed momentum in Fortive's Advanced Healthcare Solutions segment, investor enthusiasm may remain muted
Eight of 20 brokerages rate the stock "buy" or higher, twelve "hold"; their median PT is $57 - data compiled by LSEG
As of last close, stock had fallen 13.8% YTD